Vanberra Signal

Indivumed Therapeutics

Curated by Signal

AI-powered platform to discover novel therapeutic targets through precision oncology

Overview

AI-powered platform to discover novel therapeutic targets through precision oncology. The company utilizes nRavel with unique datasets to drive the discovery of therapeutic drug targets, the assessment of molecular signaling pathways, and the identification of biomarkers and gene signatures for the stratification of cancer patients.

Key facts

Founded
2002
Headquarters
Hamburg, Germany

Business model

Contact

Open roles

1 role
  • Director Bioinformatics (m/f/d)

    Hamburg, Hamburg, Germany · On-site · Full-time

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online video-based fitness courses

    Health TechnologyBerlin, Germany
  • Digital telepathology solutions for clinicians

    Health TechnologyCologne, Germany
  • Provider of wearable independent application for body weight tracking

    Health TechnologyMunich, Germany

About Indivumed Therapeutics

What does Indivumed Therapeutics do?

AI-powered platform to discover novel therapeutic targets through precision oncology.

Where is Indivumed Therapeutics headquartered?

Indivumed Therapeutics is headquartered in Hamburg, Germany.

When was Indivumed Therapeutics founded?

Indivumed Therapeutics was founded in 2002.

Which sector is Indivumed Therapeutics in?

Indivumed Therapeutics operates in Health Technology.

Who are Indivumed Therapeutics's competitors?

Companies similar to Indivumed Therapeutics include Fitnessschool, PathoZoom, and Libra.

Is Indivumed Therapeutics hiring?

Yes. Indivumed Therapeutics has 1 open role listed on Vanberra Signal.